Cargando…
Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis
BACKGROUND: This retrospective cohort study assessed benefits and risks of bedaquiline treatment in multidrug-resistant-tuberculosis (MDR-TB) combination therapy by evaluating safety, effectiveness, drug utilization and emergence of resistance to bedaquiline. METHODS: Data were extracted from a regi...
Autores principales: | Pai, Helen, Ndjeka, Norbert, Mbuagbaw, Lawrence, Kaniga, Koné, Birmingham, Eileen, Mao, Gary, Alquier, Lori, Davis, Kourtney, Bodard, Arianne, Williams, Abeda, Van Tongel, Magalie, Thoret-Bauchet, Florence, Omar, Shaheed V., Bakare, Nyasha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682840/ https://www.ncbi.nlm.nih.gov/pubmed/36414938 http://dx.doi.org/10.1186/s12879-022-07861-x |
Ejemplares similares
-
A prospective patient registry to monitor safety, effectiveness, and utilisation of bedaquiline in patients with multidrug-resistant tuberculosis in South Korea
por: Shim, Tae Sun, et al.
Publicado: (2023) -
Defining Bedaquiline Susceptibility, Resistance, Cross-Resistance and Associated Genetic Determinants: A Retrospective Cohort Study
por: Ismail, Nazir A., et al.
Publicado: (2018) -
Impact of Rv0678 mutations on patients with drug-resistant TB treated with bedaquiline
por: Kaniga, K., et al.
Publicado: (2022) -
Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis
por: Mbuagbaw, Lawrence, et al.
Publicado: (2019) -
Bedaquiline for multidrug-resistant TB in paediatric patients
por: Moodliar, R., et al.
Publicado: (2021)